Biofeedback efficacy for outlet dysfunction constipation: Clinical outcomes and predictors of response by a limited approach
BF is the therapy of choice for refractory constipation due to FDD of any etiology, inducing both clinical and anorectal physiology improvement in the short term. Comorbid IBS-C did not affect outcome while symptomatic isolated pelvic floor abnormalities appeared refractory to behavior treatment. The straining questionnaire and augmented-DRE outcomes showed a strong correlation with BF response and can be implemented in clinical practice to improve the management of constipated patients by prompting early referral to BF.
Authors
- Massimo Bellini (ORCID: https://orcid.org/0000-0002-6387-6443)
- Christian Lambiase (ORCID: https://orcid.org/0000-0002-9565-5039)
- William E. Whitehead (ORCID: https://orcid.org/0000-0001-6587-7602)
- Stefan‐Lucian Popa (ORCID: https://orcid.org/0000-0002-5508-2598)
- Riccardo Morganti (ORCID: https://orcid.org/0000-0001-7783-0262)
- Giuseppe Chiarioni
Institutions
- University of Pisa (IT)
- University of North Carolina at Chapel Hill (US)
- University of Verona (IT)
- Nottingham University Hospitals NHS Trust (GB)
- University of Nottingham (GB)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- NIHR Nottingham Digestive Diseases Biomedical Research Unit (GB)
- Azienda Ospedaliera Universitaria Pisana (IT)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1111/nmo.14948
- Citations
- 4
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.86